Dr. Joshua Milner, an allergist and immunologist who has made key discoveries into the origin of previously unidentified disorders that affect children and families, has been awarded the second annual Gale and Ira Drukier Prize in Children’s Health Research.
Bridge Medicines, a pioneering drug discovery company focused on advancing promising early technologies from concept to clinic, announced today the appointment of William J. Polvino, M.D., as Chief Executive Officer.
Researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have received two grants from the Sohn Conference Foundation to advance their investigation into how cancer spreads in children.
Dr. Virginia Pascual, a renowned physician-scientist specializing in pediatric rheumatology, has been appointed the founding Gale and Ira Drukier Director of the Gale and Ira Drukier Institute for Children’s Health.
The natural lifecycle of cells that line the intestine is critical to preserving stable conditions in the gut, according to new research led by a Weill Cornell Medicine investigator. The findings may lead to the development of new therapies to alleviate inflammatory bowel disease (IBD) and other chronic inflammatory illnesses.
The Junior Faculty Fellowship Fund, which provides $50,000 in research support to exceptional junior faculty who are juggling basic or clinical research with childcare responsibilities, recently made awards to five Weill Cornell Medicine scientists and physicians.